English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52728220    線上人數 :  536
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 561-570 / 1656 (共166頁)
<< < 52 53 54 55 56 57 58 59 60 61 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-02-02T02:21:42Z T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement Kuo S.-H.; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; MING-SHIANG WU; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T.
臺大學術典藏 2021-02-02T00:47:06Z Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Yeong-Shiau Pu;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; YEONG-SHIAU PU; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y.
臺大學術典藏 2021-02-02T00:47:06Z A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer Lin C.-C.;Hsu C.-H.;Chen J.;Tsai T.-C.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Chen J.; Tsai T.-C.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:47:06Z Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma Hsu C.-H.;Chen J.;Wu C.-Y.;Cheng A.-L.;Yeong-Shiau Pu; Hsu C.-H.; Chen J.; Wu C.-Y.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:47:00Z Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:47:00Z Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study Lin C.-C.;Hsu C.-H.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:59Z Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Cheng A.-L.;Vogelzang N.J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:57Z Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:57Z Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial Lin C.-C.;Hsu C.-H.;Hour T.-C.;Cheng A.-L.;Huang C.-Y.;Huang K.-H.;Chen J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:57Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU

顯示項目 561-570 / 1656 (共166頁)
<< < 52 53 54 55 56 57 58 59 60 61 > >>
每頁顯示[10|25|50]項目